Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120306) titled 'An Observational Study of Longitudinal Serum Proteomic and Metabolomic Profiling to Identify Biomarkers Associated With Immunotherapy Response in Advanced Metastatic Renal Cell Carcinoma' on March 12.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Renji Hospital, Shanghai Jiaotong University School of Medicine
Condition:
Kidney Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-15
Target Sample Size: case series:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=302929
Published by HT ...